Celluminova

Edinburgh Molecular Imaging

This company develops fluorescent imaging agents to help clinicians detect and visualise cancer and other diseases in real time during medical procedures.

Cellvoyant

Cellvoyant develops AI-powered imaging platforms and services to predict and optimise stem cell differentiation for biotechnology and pharmaceutical organisations developing cell-based therapies.

Fluolink

Fluolink develops optical guidance systems and fluorescence spectroscopy sensors for neurosurgeons to identify brain tumours and cerebral microcirculation during surgical procedures.

Mosaic Biomedicals

This drug discovery company develops personalised cancer treatments targeting stem cells and the immune system for patients with solid tumours.

Verinnogen

This company develops handheld 3D surface-profiling devices for measuring subcutaneous tumours to support pre-clinical oncology researchers and drug developers.

Neurolase

This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.

Stemnovate

This company develops human cell-based platforms for drug discovery and toxicity testing to support pharmaceutical firms and research institutions.

Cellanome

This company develops a multi-omics platform that integrates imaging and sequencing for single-cell analysis to serve biotechnology researchers and drug developers.